Laboratoire du Développement Normal et Pathologique du Système Immunitaire, Inserm, Unité 768, Hôpital Necker Enfants-Malades, Paris, France.
Blood. 2011 Jul 14;118(2):252-61. doi: 10.1182/blood-2011-01-328849. Epub 2011 May 4.
The present study focuses on a large family with an X-linked immunodeficiency in which there are variable clinical and laboratory phenotypes, including recurrent viral and bacterial infections, hypogammaglobulinemia, Epstein-Barr virus-driven lymphoproliferation, splenomegaly, colitis, and liver disease. Molecular and genetic analyses revealed that affected males were carriers of a hypomorphic hemizygous mutation in XIAP (XIAP(G466X)) that cosegregated with a rare polymorphism in CD40LG (CD40 ligand(G219R)). These genes are involved in the X-linked lymphoproliferative syndrome 2 and the X-linked hyper-IgM syndrome, respectively. Single expression of XIAP(G466X) or CD40L(G219R) had no or minimal effect in vivo, although in vitro, they lead to altered functional activities of their gene products, which suggests that the combination of XIAP and CD40LG mutations contributed to the expression of clinical manifestations observed in affected individuals. Our report of a primary X-linked immunodeficiency of oligogenic origin emphasizes that primary immunodeficiencies are not caused by a single defective gene, which leads to restricted manifestations, but are likely to be the result of an interplay between several genetic determinants, which leads to more variable clinical phenotypes.
本研究关注一个具有 X 连锁免疫缺陷的大家庭,其中存在可变的临床和实验室表型,包括复发性病毒和细菌感染、低丙种球蛋白血症、EB 病毒驱动的淋巴增生、脾肿大、结肠炎和肝病。分子和遗传分析表明,受影响的男性是 XIAP(XIAP(G466X))半合子隐性突变的携带者,该突变与 CD40LG(CD40 配体(G219R))中的罕见多态性共分离。这两个基因分别参与 X 连锁淋巴组织增生综合征 2 和 X 连锁高免疫球蛋白 M 综合征。尽管体外实验表明,XIAP(G466X)或 CD40L(G219R)的单一表达在体内没有或仅有微小影响,但它们导致其基因产物的功能活性发生改变,这表明 XIAP 和 CD40LG 突变的组合导致了受影响个体观察到的临床表现的表达。我们报告的原发性 X 连锁免疫缺陷的寡基因起源强调,原发性免疫缺陷不是由单个缺陷基因引起的,这些基因导致受限的表现,而是可能是几个遗传决定因素相互作用的结果,导致更可变的临床表型。